The purpose of this study was to synthesize a series of PMI-M3 dual-targeting MDM2/MDMX-based staple peptides by solid-phase synthesis, purify and lyophilize the pure products, and then measure the anti-tumor cell activity. This evidence concerns the gene MDM2 and neoplasm.